Next-generation MEK inhibitors are also available, such as RO5126766, which is defined as a dual Raf/MEK inhibitor that complexes with both proteins and inhibits phosphorylation of ERK in NRAS melanoma cells and in KRAS mutant xenograft models [174,175]. This evidence concerns the gene MAP2K7 and melanoma.